4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000146
Director sold 200 shares at $46.28 ($9,256)
- Director acquired 200 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scadden David · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +200 | $18.09 | $3,618 | 15,683 | D |
| 2024-12-11 | Sale : show line 2 in the form 10b5-1 | −200 | $46.28 | $9,256 | 15,483 | D |
| Open-market sales · 200 sh · avg $46.28 · $9,256 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-11 | Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) | −200 | 29,107 | D |
Loading xslF345X05/wk-form4_1734123872.xml…